QIAGEN - 26 Year Stock Price History | QGEN

Historical daily share price chart and data for QIAGEN since 1996 adjusted for splits. The latest closing stock price for QIAGEN as of September 23, 2022 is 41.32.
  • The all-time high QIAGEN stock closing price was 59.59 on July 17, 2000.
  • The QIAGEN 52-week high stock price is 58.00, which is 40.4% above the current share price.
  • The QIAGEN 52-week low stock price is 40.99, which is 0.8% below the current share price.
  • The average QIAGEN stock price for the last 52 weeks is 49.06.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
QIAGEN Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2022 47.2465 54.3000 54.3000 41.3200 41.3200 -25.66%
2021 51.7858 53.3100 56.8300 46.2500 55.5800 5.17%
2020 44.6405 33.9300 54.7400 33.1700 52.8500 56.36%
2019 37.0654 34.1300 43.1000 25.4100 33.8000 -1.89%
2018 35.1436 31.3600 39.3900 31.0100 34.4500 11.38%
2017 31.4871 29.3054 35.3700 27.8100 30.9300 6.30%
2016 25.1400 27.7373 29.7208 20.9665 29.0977 1.34%
2015 26.4019 24.2688 29.2950 23.1681 28.7135 17.86%
2014 23.9170 24.4350 26.1485 20.7796 24.3623 -1.47%
2013 21.6478 19.5023 25.5981 19.1596 24.7258 31.19%
2012 17.4983 14.7046 19.9385 14.7046 18.8479 31.42%
2011 17.9325 20.6135 22.8773 13.1365 14.3412 -29.36%
2010 21.1582 23.5315 24.9023 17.6746 20.3019 -12.45%
2009 19.5703 17.7681 24.0196 15.4004 23.1888 27.16%
2008 20.1357 22.5969 24.2896 13.4065 18.2354 -16.58%
2007 18.9271 16.2415 24.4558 15.9092 21.8596 39.13%
2006 14.8951 12.5031 16.7712 12.1708 15.7119 28.77%
2005 12.6618 11.4542 14.2996 10.9662 12.2019 7.31%
2004 12.0103 12.7938 16.2104 9.0762 11.3712 -8.44%
2003 9.1969 5.6908 13.3442 5.4000 12.4200 130.44%
2002 11.3746 19.7515 21.6104 4.6835 5.3896 -72.04%
2001 23.1768 36.3462 36.7408 12.8562 19.2738 -46.34%
2000 41.6247 21.2885 59.5869 19.5361 35.9204 83.26%
1999 11.2356 8.5024 21.6779 8.5024 19.6010 150.62%
1998 7.6380 5.8258 9.8654 5.4363 7.8209 35.03%
1997 5.2753 3.2945 7.6587 3.1478 5.7920 73.28%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $9.383B $2.252B
QIAGEN N.V. is one of the world's leading providers of technologies and products for the separation, purification and handling of nucleic acids DNA/RNA. The company provides innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. It has developed a comprehensive portfolio of proprietary, consumable products, and automated solutions for sample collection. Qiagen has subsidiaries several other countries with good sales potential. Segment Details Consumables: These are typically sample preparation or test kits that contain all the necessary reagents and buffers, and a manual including protocols and relevant background information. Automated Instruments: These automate the use of Sample & Assay Technologies into efficient solutions for a broad range of laboratory needs. Customer Classes: QIAGEN focuses on 4 principal segments or customer classes for sample and assay technologies:? Molecular Diagnostics, Applied Testing, Pharma and Academia.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $150.984B 9.16
GSK (GSK) United Kingdom $59.709B 7.17
Bio-Rad Laboratories (BIO.B) United States $12.433B 27.47
Biohaven Pharmaceutical Holding (BHVN) United States $10.873B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.998B 0.00
Arcus Biosciences (RCUS) United States $1.819B 35.51
Myovant Sciences (MYOV) United Kingdom $1.614B 0.00
Emergent Biosolutions (EBS) United States $1.040B 6.03
ADC Therapeutics SA (ADCT) Switzerland $0.376B 0.00
Zymeworks (ZYME) Canada $0.305B 0.00
Enzo Biochem (ENZ) United States $0.105B 0.00
Gelesis Holdings (GLS) United States $0.081B 0.00
SQZ Biotechnologies (SQZ) United States $0.068B 0.00
Ambrx Biopharma (AMAM) United States $0.041B 0.00